查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1303701

COVID-19 檢測市場：按試劑盒類型、測試類型、檢體類型、用途- 2023-2030 年全球預測

COVID-19 Testing Market by Kit Type, Test Type, Specimen Type, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球COVID-19檢測市場預計將大幅成長，到2023年將達到388.4億美元的驚人規模，到2030年將達到766.9億美元，年複合成長率10.13%。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球 COVID-19 檢測市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.COVID-19檢測的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球 COVID-19 檢測市場的抑制要素和影響是什麼？

3.在預測期內，全球 COVID-19 測試市場需要投資哪些產品/細分市場/應用程式/領域？

4.全球COVID-19檢測市場的競爭策略是什麼？

5.全球COVID-19檢測市場的技術趨勢和法律規範是什麼？

6.全球COVID-19檢測市場主要供應商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球 COVID-19 檢測市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 全球範圍內感染疾病新型冠狀病毒的患者數量正在增加
      • 政府加大力度實施大規模檢測
      • 全球患者數量不斷增加，急需快速診斷
    • 抑制因素
      • 醫務人員缺乏預防意識
    • 機會
      • 新進入者專注於家庭測試和高級軟體整合
      • COVID-19檢測設備的開發和創新
    • 任務
      • 擔心診斷試劑盒短缺
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 按試劑盒類型分類的 COVID-19 測試市場

  • 快速檢測套組
  • 即時逆轉錄聚合酶鍊式反應 (RT-PCR)

第7章 按測試類型分類的 COVID-19 測試市場

  • 多次NAAT
  • NAAT 照護端
  • 單一核酸核酸增幅檢查

第8章 按樣本類型分類的 COVID-19 測試市場

  • 血
  • 鼻拭子
  • 鼻咽拭子
  • 口咽拭子
  • 尿

第9章 COVID-19 測試市場：按用途

  • 診所
  • 診斷中心
  • 醫院

第10章 美洲 COVID-19 測試市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區 COVID-19 檢測市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲 COVID-19 檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-02026C4C988F

The Global COVID-19 Testing Market is forecasted to grow significantly, with a projected USD 38.84 billion in 2023 at a CAGR of 10.13% and expected to reach a staggering USD 76.69 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global COVID-19 Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global COVID-19 Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Kit Type, market is studied across Rapid Test Kit and Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR). The Rapid Test Kit is projected to witness significant market share during forecast period.

Based on Test Type, market is studied across Multiplex NAATs, NAAT Point of Care, and Singleplex Nucleic Acid Amplification Tests. The NAAT Point of Care is projected to witness significant market share during forecast period.

Based on Specimen Type, market is studied across Blood, Nasal Swab, Nasopharyngeal Swab, Oropharyngeal Swab, and Urine. The Nasal Swab is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinics, Diagnostic Centers, and Hospitals. The Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global COVID-19 Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global COVID-19 Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global COVID-19 Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global COVID-19 Testing Market?

4. What is the competitive strategic window for opportunities in the Global COVID-19 Testing Market?

5. What are the technology trends and regulatory frameworks in the Global COVID-19 Testing Market?

6. What is the market share of the leading vendors in the Global COVID-19 Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global COVID-19 Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. COVID-19 Testing Market, by Kit Type, 2022 vs 2030
  • 4.3. COVID-19 Testing Market, by Test Type, 2022 vs 2030
  • 4.4. COVID-19 Testing Market, by Specimen Type, 2022 vs 2030
  • 4.5. COVID-19 Testing Market, by Application, 2022 vs 2030
  • 4.6. COVID-19 Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of COVID-19-infected patients globally
      • 5.1.1.2. Rising government initiatives toward the implementation of mass testing
      • 5.1.1.3. Increasing patient population globally and enormous need for speedy diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness among medical professionals about precautions
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus of new entrants toward at-home testing and integration of advanced software
      • 5.1.3.2. Development and innovations in COVID-19 testing devices
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with scarcity of diagnostic kits
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. COVID-19 Testing Market, by Kit Type

  • 6.1. Introduction
  • 6.2. Rapid Test Kit
  • 6.3. Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR)

7. COVID-19 Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Multiplex NAATs
  • 7.3. NAAT Point of Care
  • 7.4. Singleplex Nucleic Acid Amplification Tests

8. COVID-19 Testing Market, by Specimen Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Nasal Swab
  • 8.4. Nasopharyngeal Swab
  • 8.5. Oropharyngeal Swab
  • 8.6. Urine

9. COVID-19 Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Diagnostic Centers
  • 9.4. Hospitals

10. Americas COVID-19 Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific COVID-19 Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa COVID-19 Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. COVID-19 TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. COVID-19 TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2022 VS 2030 (%)
  • FIGURE 5. COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
  • FIGURE 6. COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2022 VS 2030 (%)
  • FIGURE 7. COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. COVID-19 TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. COVID-19 TESTING MARKET DYNAMICS
  • FIGURE 10. COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. COVID-19 TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. COVID-19 TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. COVID-19 TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. COVID-19 TESTING MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. COVID-19 TESTING MARKET SIZE, BY REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. COVID-19 TESTING MARKET SIZE, BY MULTIPLEX NAATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. COVID-19 TESTING MARKET SIZE, BY NAAT POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. COVID-19 TESTING MARKET SIZE, BY SINGLEPLEX NUCLEIC ACID AMPLIFICATION TESTS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. COVID-19 TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. COVID-19 TESTING MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. COVID-19 TESTING MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. COVID-19 TESTING MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. COVID-19 TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. COVID-19 TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. COVID-19 TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. COVID-19 TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. COVID-19 TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 190. COVID-19 TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 191. COVID-19 TESTING MARKET LICENSE & PRICING